Yale Cancer Center's involvement in cancer clinical trials
Yale Cancer Center NCTN LAPS
This study is all about working together with top cancer experts to improve treatments for cancer patients by running important clinical trials, so if you're looking for new ways to fight cancer, this could be for you!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10795026 on NIH RePORTER |
What this research studies
This research focuses on Yale Cancer Center's active participation in the National Clinical Trials Network (NCTN), aiming to enhance cancer treatment through collaborative clinical trials. The approach involves prioritizing patient accrual to these trials and fostering leadership roles for faculty within various trial groups. By leveraging translational science, the project seeks to integrate promising pilot trial results into larger multi-center studies, ultimately improving cancer care and outcomes for patients. The research emphasizes collaboration among leading experts in oncology to drive advancements in cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for participation are patients diagnosed with various types of cancer who are seeking cutting-edge treatment options through clinical trials.
Not a fit: Patients with non-malignant conditions or those who do not meet the eligibility criteria for specific trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment options and outcomes for patients through innovative clinical trials.
How similar studies have performed: Previous research has shown success in similar collaborative clinical trial approaches, indicating a strong potential for impactful outcomes.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Chiang, Anne C — Yale University
- Study coordinator: Chiang, Anne C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.